propranolol hydrochloride 24 HR Propranolol Hydrochloride 60 MG Extended Release Oral Capsule
INDICATIONS AND USAGE Hypertension Propranolol Hydrochloride Extended-Release Capsules, USP, are indicated in the management of hypertension. They may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol Hydrochloride Extended-Release Capsules, USP, are not indicated in the management of hypertensive emergencies. Angina Pectoris Due to Coronary Atherosclerosis Propranolol Hydrochloride Extended-Release Capsules, USP, are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Migraine Propranolol Hydrochloride Extended-Release Capsules, USP, are indicated for the prophylaxis of common migraine headache. The efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. Hypertrophic Subaortic Stenosis Propranolol Hydrochloride Extended-Release Capsules, USP, improve NYHA functional class in symptomatic patients with Hypertrophic Subaortic Stenosis.
Breckenridge Pharmaceutical, Inc.
Related Pills
propranolol hydrochloride capsule extended release
breckenridge pharmaceutical, inc.
propranolol hydrochloride 24 HR Propranolol Hydrochloride 80 MG Extended Release Oral Capsule
Breckenridge Pharmaceutical, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
PROPRANOLOL HYDROCHLORIDE Extended-Release capsules, USP. Each white/opaque capsule, imprinted with "60"on cap and "RD203" on body contains 60 mg of
PROPRANOLOL HYDROCHLORIDE in bottles of 100 (NDC 51991-817-01) and 500 (NDC 51991-817-05). Each capsule with white/opaque body and orange/opaque cap, imprinted with "80"on cap and "RD203" on body contains 80 mg of
PROPRANOLOL HYDROCHLORIDE in bottles of 100 (NDC 51991-818-01) and 500 (NDC 51991-818-05). Each orange/opaque capsule, imprinted with "120"on cap and "RD203" on body contains 120 mg of
PROPRANOLOL HYDROCHLORIDE in bottles of 100 (NDC 51991-819-01) and 500 (NDC 51991-819-05). Each light brown/opaque capsule, imprinted with "160"on cap and "RD203" on body contains 160 mg of
PROPRANOLOL HYDROCHLORIDE in bottles of 100 (NDC 51991-820-01) and 500 (NDC 51991-820-05). Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from light, moisture, freezing, and excessive heat. Dispense in a tight, light-resistant container as defined in the USP.
More pills like CAPSULE 60 RD203